Clinical Trials Browser

Withdrawn × Interventional × EBV Lymphomas × Clear all

NCT03988582 2020-06-11

Safety and Effectiveness of EBV-specific Cytotoxic T Cells for the Treatment for EBV Lymphomas or Other EBV-associated Malignancies

Phase 2 Withdrawn

EBV Lymphomas